Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Oval 19 mm, Extended release tablet with imprint "V04;". It contains Nevirapine 400 mg; of Nevirapine[nevirapine];. This belongs to the Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor pharmacologic class. It is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.. For details please contact your physician.
Basic Information
- Imprint
- V04;
- Color
- Yellow
- Shape
- Oval
- Size
- 19 mm
Drug Information
- Strength
- Nevirapine 400 mg;
- Dosage Form
- Extended release tablet
- RxCUI
- 1095715
Pharmaceutical Classification
Related Medications
Other drugs in the same class: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- AtriplaEFAVIRENZ 600 mg;EMTRICITABINE 200 mg;TENOFOVIR DISOPROXIL FUMARATE 300 mg;PINK • OVAL
- COMPLERAemtricitabine 200 mg;rilpivirine hydrochloride 25 mg;tenofovir disoproxil fumarate 300 mg;PURPLE • OVAL
- EDURANTrilpivirine hydrochloride 25 mg;WHITE • ROUND
- Intelenceetravirine 100 mg;WHITE • OVAL
- Intelenceetravirine 200 mg;WHITE • OVAL
- nevirapineNEVIRAPINE 200 mg;WHITE • CAPSULE
- NevirapineNEVIRAPINE 200 mg;WHITE • OVAL
- SUSTIVAefavirenz 200 mg;YELLOW • CAPSULE
- SUSTIVAefavirenz 50 mg;WHITE;YELLOW • CAPSULE
- SUSTIVAefavirenz 600 mg;YELLOW • OVAL
Ingredients
- Active Ingredients
- Nevirapine[nevirapine];
Additional Information
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Viramune
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.